Follow-up behaviours of individuals who attended a community-based diabetes screening program

Canadian Journal of Diabetes

Volumn 28, Issue 3, 2004, Pages 210-218

  Strychar, Irene ^a,b   Yale, Jean François ^c   Aris Jilwan, Nahla ^a   Marchand, Robert ^d   Bonin, André ^e   Dion, Isabelle ^a,b   Ishac, Alain ^a,b   Champagne, François ^b  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d Ministere de la Sante et des Services Sociaux   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Blood glucose; Community based diabetes screening program; Impaired fasting glucose; Impaired glucose tolerance; Prediabetes; Prevention; Risk factors

Indexed keywords

GLUCOSE;

ARTICLE; BEHAVIOR; CONSULTATION; DIABETES EDUCATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; PUBLIC HEALTH; PUBLICATION; RISK FACTOR; SCREENING; TELECOMMUNICATION;

EID: 28844442853     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S1-S152.
2. Adler A, Drucker S, Feldman R, et al. Emerging insights into the impact of metabolic and vascular mechanisms of hyperin-sulinemia and dyslipidemia on the clinical management of type 2 diabetes. Insulin Resistance Report. Based on data presented at the Canadian Working Group on Insulin Resistance Conference, Lake Louise, Alberta, April 25-28, 2002.
3. Health Canada. Diabetes in Canada. National Statistics and Opportunities for Improved Surveillance, Prevention, and Control. Ottawa, ON: Minister of Public Works and Government Services Canada; 1999. Publication H49-121/1999.
4. Harris MI, Flegal KM, Goldstein DE, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
5. Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15:815-819.
6. Harris MI. Undiagnosed NIDDM: Clinical and public health issues. Diabetes Care. 1993;16:642-652.
7. Ballard DJ, Humphrey LL, Melton LJ, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus: Population-based study in Rochester, Minnesota. Diabetes. 1988;37:405-412.
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2001;24(suppl 1):S5-S20.
9. Dunbar M, Ludwig S. The haute couture approach to type 2 diabetes [editorial]. Can Diabetes. 2001;14(3):1-2.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
11. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
12. Ludwig S, Ash C. Messages from the United Kingdom Prospective Diabetes Study. Can Diabetes. 1998;11(4):1-7.
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
14. Gerstein HC, Hanna A, Rowe R, et al. CDA position statement regarding the UKPDS and revision of diabetes clinical practice guidelines accounting for the UKPDS results. Can J Diabetes Care. 1999;23:15-17.
15. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
16. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
17. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: The 6-year Malmo feasibility study. Diabetologia. 1991;34:891-898.
18. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
19. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-2803.
20. Chiasson J-L, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet. 2002;359:2072-2077.
21. American Diabetes Association, National Institute of Diabetes, Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care. 2003;26(suppl 1):S62-S69.
22. Harwell TS, Smilie JG, McDowall JM, et al. Diabetes screening practices among individuals aged 45 years and older. Diabetes Care. 2000;23:125-126.
23. Cowie CC, Harris MI, Eberhardt MS. Frequency and determinants of screening for diabetes in the U.S. Diabetes Care. 1994;17:1158-1163.
24. Leiter LA, Barr A, Bélanger A, et al. Diabetes Screening in Canada (DIASCAN) study. Prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care. 2001;24:1038-1043.
25. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2003;26(suppl 1):S21-S24.
26. Marshall KG. The folly of population screening for type 2 diabetes. CMAJ. 1999;160:1592-1593.
27. Gerstein HC, Meltzer S. Preventive medicine in people at high risk for chronic disease: The value of identifying and treating diabetes. CMAJ. 1999;160:1593-1595.
28. Marshall KG. Rebuttal, Dr. Marshall responds. CMAJ. 1999;160:1595-1596.
29. Gerstein HC, Meltzer S. Rebuttal, Drs. Gerstein and Meltzer respond. CMAJ. 1999;160:1596.
30. Engelgau MM, Aubert RE, Thompson TJ, et al. Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and recommendations. Diabetes Care. 1995;18:1606-1618.
31. Harris R, Donahue K, Rathore SS, et al. Screening adults for type 2 diabetes: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:215-229.
32. Street RL, Piziak VK, Carpentier WS, et al. Provider-patient communication and metabolic control. Diabetes Care. 1993;16:714-721.
33. Wallerstein N. Powerlessness, empowerment, and health: Implications for health promotion programs. Am J Health Promot. 1992;6:197-205.
34. Hunt LM, Arar NH, Larme AC. Contrasting patient and practitioner perspectives in type 2 diabetes management. West J Nurs Res. 1998;20:656-676, 677-682.
35. Robinson R, Carriere KC, Young TK, et al. Health care seeking behavior following a health survey: Impact on prevalence estimates of chronic diseases. J Clin Epidemiol. 2000;53:681-687.
36. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ. 1998;159(suppl 8):S1-S29.
37. Tietz NW, ed. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia, PA: WB Saunders; 1995:274.
38. Bourn D, Mann J. Screening for noninsulin dependent diabetes mellitus and impaired glucose tolerance in a Dunedin general practice-is it worth it?. N Z Med J. 1992;105:208-210.
39. Lawrenson RA, Dunn PJ, Jury D, et al. Discover diabetes: Screening for diabetes mellitus in the Waikato. N Z Med J. 1993;106:522-524.
40. Newman WP, Nelson R, Scheer K. Community screening for diabetes. Low detection rate in a low-risk population. Diabetes Care. 1994;17:363-365.
41. O'Connor PJ, Rush WA, Cherney LM, et al. Screening for diabetes mellitus in high-risk patients: Cost, yield, and acceptability. Eff Clin Pract. 2001;4:271-277.
42. Engelgau MM, Narayan KMV, Herman WH. Screening for type 2 diabetes. Diabetes Care. 2000;23:1563-1580.